标题
Survivin in Solid Tumors: Rationale for Development of Inhibitors
作者
关键词
-
出版物
Current Oncology Reports
Volume 14, Issue 2, Pages 120-128
出版商
Springer Nature
发表日期
2012-01-11
DOI
10.1007/s11912-012-0215-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- YM155, a novel survivin suppressant, enhances taxane-induced apoptosis and tumor regression in a human Calu 6 lung cancer xenograft model
- (2011) Takahito Nakahara et al. ANTI-CANCER DRUGS
- Antitumor Activity of YM155, a Selective Small-Molecule Survivin Suppressant, Alone and in Combination with Docetaxel in Human Malignant Melanoma Models
- (2011) Kentaro Yamanaka et al. CLINICAL CANCER RESEARCH
- Silencing Survivin Splice Variant 2B Leads to Antitumor Activity in Taxane-Resistant Ovarian Cancer
- (2011) P. E. Vivas-Mejia et al. CLINICAL CANCER RESEARCH
- Antisense Inhibition of Survivin Expression as a Cancer Therapeutic
- (2011) R. A. Carrasco et al. MOLECULAR CANCER THERAPEUTICS
- Association of Long-term Administration of the Survivin mRNA-Targeted Antisense Oligonucleotide LY2181308 With Reversible Kidney Injury in a Patient With Metastatic Melanoma
- (2010) William G. Herrington et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Marked anti-tumour activity of the combination of YM155, a novel survivin suppressant and platinum-based drugs
- (2010) T Iwasa et al. BRITISH JOURNAL OF CANCER
- Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors
- (2010) M. Tanioka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Global Targeting of Subcellular Heat Shock Protein-90 Networks for Therapy of Glioblastoma
- (2010) M. D. Siegelin et al. MOLECULAR CANCER THERAPEUTICS
- Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions
- (2009) Michel R Nasr et al. AMERICAN JOURNAL OF DERMATOPATHOLOGY
- Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability
- (2009) C. A. Pise-Masison et al. BLOOD
- Endogenous Tumor Suppression Mediated by PTEN Involves Survivin Gene Silencing
- (2009) M. Guha et al. CANCER RESEARCH
- Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
- (2009) J. Lu et al. CLINICAL CANCER RESEARCH
- Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors
- (2009) T. Satoh et al. CLINICAL CANCER RESEARCH
- Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer
- (2009) Giuseppe Giaccone et al. JOURNAL OF CLINICAL ONCOLOGY
- Caspase 2-mediated tumor suppression involves survivin gene silencing
- (2009) M Guha et al. ONCOGENE
- Insulin-like Growth Factor-I Receptor Signaling Pathway Induces Resistance to the Apoptotic Activities of SCH66336 (Lonafarnib) through Akt/Mammalian Target of Rapamycin-Mediated Increases in Survivin Expression
- (2008) S. H. Oh et al. CLINICAL CANCER RESEARCH
- SPC3042: a proapoptotic survivin inhibitor
- (2008) J. B. Hansen et al. MOLECULAR CANCER THERAPEUTICS
- Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
- (2008) Rui-Hong Wang et al. MOLECULAR CELL
- New wirings in the survivin networks
- (2008) D C Altieri ONCOGENE
- Chemically synthesized human survivin does not inhibit caspase-3
- (2008) Changqing Li et al. PROTEIN SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started